Aggregometry and thromboelastography to identify the timing to trach a COVID‐19 patient receiving both antiplatelet therapy and enoxaparin

In COVID‐19 patients receiving enoxaparin and antiplatelets therapy, aggregometry and thromboelastography might be considered an adjunctive tool to identify the time to perform procedures at risk of bleeding, such as tracheostomy. In COVID‐19 patients receiving enoxaparin and antiplatelets therapy,...

Full description

Saved in:
Bibliographic Details
Published in:Clinical case reports 2021-03, Vol.9 (3), p.1049-1054
Main Authors: Tescione, Marco, Vadalà, Eugenio, Marano, Graziella, Bruni, Andrea, Garofalo, Eugenio, Lavalle, Ovidia, Longhini, Federico, Battaglia, Enzo, Polimeni, Nicola, Labate, Demetrio, Caracciolo, Sarah, Giordano, Francesco, Caracciolo, Massimo, Macheda, Sebastiano
Format: Article
Language:English
Subjects:
aggregometry
Antibiotics
Anticoagulants
Blood
Blood platelets
Case Report
Case Reports
Coronaviruses
COVID‐19
Cytokine storm
Embolisms
Failure
Fever
Infections
Intensive care
Mortality
Ostomy
Pain
Patients
Pneumonia
Proteins
SARS‐CoV‐2
thromboelastography
tracheostomy
Tracheotomy
Ventilators
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In COVID‐19 patients receiving enoxaparin and antiplatelets therapy, aggregometry and thromboelastography might be considered an adjunctive tool to identify the time to perform procedures at risk of bleeding, such as tracheostomy. In COVID‐19 patients receiving enoxaparin and antiplatelets therapy, aggregometry and thromboelastography might be considered an adjunctive tool to identify the time to perform procedures at risk of bleeding, such as tracheostomy.
ISSN:2050-0904
2050-0904
DOI:10.1002/ccr3.3442